Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate.

Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate.

Item
http://www.wikidata.org/entity/Q31147384
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Microtubule-binding agents: a dynamic field of cancer therapeutics.Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.Leukemia regression by vascular disruption and antiangiogenic therapy.Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503.Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1.Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent.Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck CancerDual targeting of tumor vasculature: combining Avastin and vascular disrupting agents (CA4P or OXi4503).
P2860

Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate.

Item
http://www.wikidata.org/entity/Q31147384
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Oxi4503, a novel vascular targ ...... combretastatin A-4 phosphate.
@ast
Oxi4503, a novel vascular targ ...... combretastatin A-4 phosphate.
@en
type
label
Oxi4503, a novel vascular targ ...... combretastatin A-4 phosphate.
@ast
Oxi4503, a novel vascular targ ...... combretastatin A-4 phosphate.
@en
prefLabel
Oxi4503, a novel vascular targ ...... combretastatin A-4 phosphate.
@ast
Oxi4503, a novel vascular targ ...... combretastatin A-4 phosphate.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
Oxi4503, a novel vascular targ ...... o combretastatin A-4 phosphate
@en
P2093
P304
P31
P407
P433
P478
P577
P698